Literature DB >> 25354934

Genetic variant in NDUFS1 gene is associated with schizophrenia and negative symptoms in Han Chinese.

Yunlong Zhu1, Zhongliang Wang1, Jianliang Ni2, Yi Zhang3, Meijuan Chen3, Jun Cai3, Xiao Li4, Wen Zhang4, Chen Zhang3.   

Abstract

Abnormalities in mitochondrial complex I, which is responsible for controlling mitochondrial function, have been implicated in a variety of diseases associated with mitochondrial dysfunction, potentially including schizophrenia. The NADH dehydrogenase Fe-S protein 1 (NDUFS1) is the largest subunit of complex I. To explore whether the encoding NDUFS1 gene confers susceptibility to schizophrenia or is associated with the severity of typical symptoms of schizophrenia, we recruited 519 stable schizophrenia patients receiving clozapine treatment and 594 healthy controls for genotyping to investigate the association of four selected tagging single-nucleotide polymorphisms (SNPs) of NDUFS1 and both schizophrenia risk and symptom severity. The severity of psychotic symptoms was evaluated using the Positive and Negative Syndrome Scale and then tested for association with the four SNPs. The SNP rs1044120 showed significant association with schizophrenia (adjusted P=0.032). The frequency of the G allele of rs1044120 was significantly higher in patients than among the healthy controls (adjusted P=0.008). Stratification by sex revealed a significant association between the rs1044120 polymorphism and schizophrenia among males (adjusted P=0.036 and 0.008 in genotypic and allelic comparisons, respectively). We also observed a significant difference in the negative symptom scores among the three genotypes among these males (adjusted P=0.036). Post hoc comparisons showed that rs1044120 G/G carriers had higher negative symptom scores than those with G/T and T/T carriers (raw P=0.035 and 0.005, respectively). Our findings suggest that NDUFS1 may confer susceptibility to schizophrenia in male subjects, acting as a causative factor for the severity of negative symptoms in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25354934     DOI: 10.1038/jhg.2014.94

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  39 in total

1.  Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients.

Authors:  Patricia Gassó; Sergi Mas; Oriol Molina; Amalia Lafuente; Miquel Bernardo; Eduard Parellada
Journal:  J Psychiatr Res       Date:  2013-10-10       Impact factor: 4.791

2.  Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia.

Authors:  Weihong Lu; Chen Zhang; Zhenghui Yi; Zezhi Li; Zhiguo Wu; Yiru Fang
Journal:  J Mol Neurosci       Date:  2012-04-03       Impact factor: 3.444

3.  A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.

Authors:  Steven G Potkin; Gustavo Alva; Kirsten Fleming; Ravi Anand; David Keator; Danilo Carreon; Michael Doo; Yi Jin; Joseph C Wu; James H Fallon
Journal:  Am J Psychiatry       Date:  2002-02       Impact factor: 18.112

4.  A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.

Authors:  Chen Zhang; Zezhi Li; Zhiguo Wu; Jun Chen; Zuowei Wang; Daihui Peng; Wu Hong; Chengmei Yuan; Zhen Wang; Shunying Yu; Yifeng Xu; Lin Xu; Zeping Xiao; Yiru Fang
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

5.  Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population.

Authors:  Zhenghui Yi; Chen Zhang; Zhiguo Wu; Wu Hong; Zezhi Li; Yiru Fang; Shunying Yu
Journal:  Brain Res       Date:  2011-08-22       Impact factor: 3.252

6.  Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population.

Authors:  Chen Zhang; Zezhi Li; Yang Shao; Bin Xie; Yasong Du; Yiru Fang; Shunying Yu
Journal:  J Mol Neurosci       Date:  2010-10-12       Impact factor: 3.444

7.  Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain.

Authors:  Jean-Ehrland Ricci; Cristina Muñoz-Pinedo; Patrick Fitzgerald; Béatrice Bailly-Maitre; Guy A Perkins; Nagendra Yadava; Immo E Scheffler; Mark H Ellisman; Douglas R Green
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

Review 8.  Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.

Authors:  Suat Ying Tan Cherlyn; Puay San Woon; Jian Jun Liu; Wei Yi Ong; Guo Chuan Tsai; Kang Sim
Journal:  Neurosci Biobehav Rev       Date:  2010-01-07       Impact factor: 8.989

9.  Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients.

Authors:  O Robicsek; R Karry; I Petit; N Salman-Kesner; F-J Müller; E Klein; D Aberdam; D Ben-Shachar
Journal:  Mol Psychiatry       Date:  2013-06-04       Impact factor: 15.992

10.  Association study of common variants within the G protein-coupled receptor kinase 6 gene and schizophrenia susceptibility in Han Chinese.

Authors:  Wenxin Tang; Jun Cai; Zhenghui Yi; Yi Zhang; Weihong Lu; Chen Zhang
Journal:  Hum Psychopharmacol       Date:  2013-12-03       Impact factor: 1.672

View more
  10 in total

1.  NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia.

Authors:  Oded Bergman; Rachel Karry; Jumana Milhem; Dorit Ben-Shachar
Journal:  Mol Psychiatry       Date:  2018-12-10       Impact factor: 15.992

2.  Comprehensive family therapy: an effective approach for cognitive rehabilitation in schizophrenia.

Authors:  Jun Cai; Yi Zhu; Weibo Zhang; Yanfeng Wang; Chen Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-21       Impact factor: 2.570

3.  The NCAN gene: schizophrenia susceptibility and cognitive dysfunction.

Authors:  Peirong Wang; Jun Cai; Jianliang Ni; Jiangtao Zhang; Wei Tang; Chen Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-11-04       Impact factor: 2.570

4.  Ndufs1 Deficiency Aggravates the Mitochondrial Membrane Potential Dysfunction in Pressure Overload-Induced Myocardial Hypertrophy.

Authors:  Rongjun Zou; Jun Tao; Junxiong Qiu; Wanting Shi; Minghui Zou; Weidan Chen; Wenlei Li; Na Zhou; Shaoli Wang; Li Ma; Xinxin Chen
Journal:  Oxid Med Cell Longev       Date:  2021-03-03       Impact factor: 6.543

5.  Identification and validation of hub genes for diabetic retinopathy.

Authors:  Li Peng; Wei Ma; Qing Xie; Baihua Chen
Journal:  PeerJ       Date:  2021-09-13       Impact factor: 2.984

6.  HSPB1 Gene Variants and Schizophrenia: A Case-Control Study in a Polish Population.

Authors:  Malgorzata Kowalczyk; Krzysztof Kucia; Aleksander Owczarek; Renata Suchanek-Raif; Monika Paul-Samojedny; Piotr Choreza; Jan Kowalski
Journal:  Dis Markers       Date:  2022-03-15       Impact factor: 3.434

7.  Do nuclear-encoded core subunits of mitochondrial complex I confer genetic susceptibility to schizophrenia in Han Chinese populations?

Authors:  Xiao Li; Wen Zhang; Jinsong Tang; Liwen Tan; Xiong-jian Luo; Xiaogang Chen; Yong-Gang Yao
Journal:  Sci Rep       Date:  2015-06-08       Impact factor: 4.379

8.  A Preliminary Genetic Analysis of Complement 3 Gene and Schizophrenia.

Authors:  Jianliang Ni; Shuangfei Hu; Jiangtao Zhang; Wenxin Tang; Weihong Lu; Chen Zhang
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

9.  Genetic association analysis of microRNA137 and its target complex 1 with schizophrenia in Han Chinese.

Authors:  Weihong Lu; Yi Zhang; Xinyu Fang; Weixing Fan; Wei Tang; Jun Cai; Lisheng Song; Chen Zhang
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

10.  NLRP3 Influences Cognitive Function in Schizophrenia in Han Chinese.

Authors:  Ruimei Liu; Wei Tang; Weiping Wang; Feikang Xu; Weixing Fan; Yi Zhang; Chen Zhang
Journal:  Front Genet       Date:  2021-12-10       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.